Further, over-expression of TIMP2 in tumour stroma was associated with increased disease-free survival in prostate cancer [32], and down-regulation of MMP2 by TIMP2 over-expression reduced tumour growth and metastatic potential in a rat model of breast cancer-associated brain metastasis [33]. Here, MMP2 is linked to prostate carcinoma.